Profile data is unavailable for this security.
About the company
ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. Its SOZO Applications include L-Dex Analysis for Lymphedema, BodyComp Analysis, Segmental BodyComp Analysis, and HF-Dex Analysis for Heart Failure. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.
- Revenue in AUD (TTM)12.72m
- Net income in AUD-23.24m
- Incorporated1999
- Employees77.00
- LocationImpediMed LtdPinkenba, U 1 50 Parker CtBRISBANE 4008AustraliaAUS
- Phone+61 73860-3700
- Fax+61 73260-1225
- Websitehttps://www.impedimed.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resonance Health Ltd | 11.16m | -1.73m | 20.42m | 18.00 | -- | 2.11 | -- | 1.83 | -0.0038 | -0.0038 | 0.0245 | 0.0204 | 0.5848 | -- | 3.82 | -- | -9.08 | -4.17 | -12.91 | -4.98 | -- | -- | -15.53 | -9.03 | -- | -6.57 | 0.2882 | -- | 26.78 | 24.65 | -1,123.59 | -- | 19.97 | -- |
| Control Bionics Ltd | 7.04m | -6.11m | 23.07m | -- | -- | 3.06 | -- | 3.28 | -0.0232 | -0.0232 | 0.0261 | 0.0183 | 0.8158 | 4.99 | 3.35 | -- | -70.78 | -48.07 | -99.30 | -55.80 | 71.14 | 68.24 | -86.77 | -98.27 | 1.08 | -33.30 | 0.0733 | -- | 16.76 | 16.36 | -3.30 | -- | 7.93 | -- |
| ImExHS Ltd | 26.35m | -4.11m | 24.32m | 400.00 | -- | 1.67 | -- | 0.9232 | -0.0861 | -0.0861 | 0.5592 | 0.2693 | 1.18 | 77.60 | 3.32 | 65,869.38 | -18.42 | -17.16 | -27.27 | -22.88 | 34.44 | 32.57 | -15.61 | -21.02 | 1.51 | -10.77 | 0.0863 | -- | 34.41 | 27.47 | 41.00 | -- | -9.90 | -- |
| CONNEQT Health Ltd | 3.55m | -18.19m | 26.94m | 26.00 | -- | 38.21 | -- | 7.58 | -0.0507 | -0.0507 | 0.01 | 0.0012 | 0.3235 | 0.4389 | 10.72 | -- | -165.59 | -99.31 | -618.20 | -249.16 | 71.97 | 84.29 | -511.88 | -208.53 | 0.6557 | -2.37 | 0.8527 | -- | -68.20 | -5.10 | -168.93 | -- | -33.92 | -- |
| Genetic Signatures Ltd | 21.36m | -20.10m | 29.53m | -- | -- | 0.5895 | -- | 1.38 | -0.0899 | -0.0899 | 0.0942 | 0.2205 | 0.3505 | 1.17 | 6.04 | -- | -32.98 | -16.72 | -35.71 | -18.31 | 56.72 | 55.89 | -94.10 | -38.67 | 9.49 | -143.04 | 0.0156 | -- | 49.69 | 8.55 | -12.55 | -- | -17.43 | -- |
| Atomo Diagnostics Ltd | 3.79m | -4.97m | 32.41m | -- | -- | 4.24 | -- | 8.55 | -0.0077 | -0.0077 | 0.0059 | 0.0094 | 0.3672 | 1.07 | 2.83 | -- | -48.13 | -30.62 | -57.46 | -33.10 | 50.62 | 40.54 | -131.08 | -113.09 | 2.27 | -- | 0.0259 | -- | -10.53 | -6.72 | 27.41 | -- | -55.73 | -- |
| ImpediMed Ltd | 12.72m | -23.24m | 36.70m | 77.00 | -- | 1.78 | -- | 2.88 | -0.0115 | -0.0115 | 0.0063 | 0.0101 | 0.2871 | 2.16 | 5.51 | 165,246.80 | -52.43 | -42.33 | -59.33 | -48.49 | 86.25 | 85.16 | -182.62 | -195.14 | 4.71 | -112.78 | 0.4142 | -- | 23.31 | 17.25 | -17.42 | -- | -14.47 | -- |
| Curvebeam AI Ltd | 12.10m | -16.84m | 38.22m | 50.00 | -- | 0.8839 | -- | 3.16 | -0.0453 | -0.0453 | 0.0323 | 0.0905 | 0.1946 | 0.6343 | 10.20 | -- | -27.10 | -- | -31.21 | -- | 44.89 | -- | -139.24 | -- | 1.22 | -80.93 | 0.3366 | -- | 85.33 | -- | 27.09 | -- | -- | -- |
| BCAL Diagnostics Ltd | 2.65m | -7.24m | 44.17m | -- | -- | 7.06 | -- | 16.67 | -0.0201 | -0.0201 | 0.0074 | 0.017 | 0.239 | -- | 0.9573 | -- | -65.31 | -57.98 | -87.92 | -72.00 | -- | -- | -273.21 | -249.54 | -- | -- | 0.2766 | -- | -13.01 | 43.11 | -13.14 | -- | 190.46 | -- |
| HeraMED Ltd | 322.93k | -4.53m | 44.55m | -- | -- | 60.80 | -- | 137.94 | -0.0059 | -0.0059 | 0.0004 | 0.0007 | 0.1381 | 0.3794 | 1.57 | -- | -193.87 | -129.03 | -316.53 | -221.14 | 58.70 | 58.67 | -1,404.05 | -2,178.90 | 2.33 | -- | 0.468 | -- | -39.90 | 11.74 | 18.96 | -- | -- | -- |
| Nova Eye Medical Ltd | 29.27m | -9.06m | 47.00m | 130.00 | -- | 2.47 | -- | 1.61 | -0.0373 | -0.0373 | 0.1183 | 0.0668 | 1.04 | 2.92 | 7.08 | -- | -32.13 | -21.38 | -39.78 | -24.97 | 64.54 | 78.66 | -30.95 | -46.44 | 1.85 | -121.42 | 0.1372 | -- | 24.81 | 17.95 | -3.06 | -- | -14.69 | -- |
| Cleanspace Holdings Ltd | 19.76m | -478.27k | 50.16m | -- | -- | 2.61 | 113.57 | 2.54 | -0.0062 | -0.0062 | 0.2538 | 0.2448 | 0.7372 | 1.95 | 4.94 | -- | -1.78 | -6.87 | -2.07 | -8.29 | 74.76 | 74.57 | -2.42 | -10.49 | 4.46 | -- | 0.1914 | -- | 25.72 | -6.99 | 84.71 | -- | -23.72 | -- |
| Vitasora Health Ltd | 3.71m | -10.11m | 50.17m | 2.00 | -- | 2.90 | -- | 13.54 | -0.0071 | -0.0071 | 0.0027 | 0.0093 | 0.3013 | 0.0106 | 4.17 | -- | -82.17 | -118.94 | -115.44 | -176.54 | 99.19 | 78.72 | -272.73 | -533.63 | 0.6694 | -- | 0.0039 | -- | 256.77 | 10.92 | -41.74 | -- | -- | -- |
Data as of Feb 15 2026. Currency figures normalised to ImpediMed Ltd's reporting currency: Australian Dollar AUD
14.22%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Paradice Investment Management Pty Ltd.as of 06 Aug 2025 | 174.19m | 8.54% |
| Australian Ethical Investments Ltd. (Investment Management)as of 06 Aug 2025 | 115.30m | 5.66% |
| DFA Australia Ltd.as of 31 Dec 2025 | 302.70k | 0.02% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 122.08k | 0.01% |
| North Star Asset Management, Inc.as of 31 Dec 2025 | 20.00k | 0.00% |
More ▼
Data from 31 Dec 2025 - 10 Feb 2026Source: FactSet Research Systems Inc.
